Latest LUNGevity Foundation Stories
Medicare Committee Decision Leaves Medicare-Reliant At Risk WASHINGTON, May 2, 2014 /PRNewswire-USNewswire/ -- LUNGevity Foundation President Andrea Ferris today commented on the Medicare
Ceritinib (brand name Zykadia(TM)) will be used for the treatment of patients with anaplastic lymphoma kinase-positive (ALK+) metastatic non-small cell lung cancer (NSCLC) who have progressed on or
Lemonade Stand Funds Fight against Lung Cancer WASHINGTON, May 1, 2014 /PRNewswire-USNewswire/ -- LUNGevity Foundation announces the Bauer family of Shaker Heights, Ohio - Harriet and her children,
Celebrating Monica's Contributions in Memoriam WASHINGTON, April 8, 2014 /PRNewswire-USNewswire/ -- LUNGevity Foundation announces Monica Barlow, formerly director of public relations
WASHINGTON, March 14, 2014 /PRNewswire-USNewswire/ -- LUNGevity Foundation is inviting lung cancer patients/survivors from across the nation to register for the fourth annual national LUNGevity HOPE
Doug Kammerer Chosen as First LUNGevity Hero WASHINGTON, March 4, 2014 /PRNewswire-USNewswire/ -- The LUNGevity Foundation announces the LUNGevity Heroes program, a monthly honor recognizing
$250,000 to support immuno-oncology learning resources WASHINGTON, March 3, 2014 /PRNewswire-USNewswire/ -- LUNGevity Foundation is honored to announce a grant of $250,000 from Bristol-Myers
New Members Contribute Expertise and Vision to LUNGevity's Research Program WASHINGTON, Feb.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.